Viusid in Adults With Acute Fever of Viral Etiology
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and effect of Viusid (bags of 4 grams)
administration in the treatment of acute fever of viral etiology as diagnosed by clinical,
hematologic and serologic parameters. The duration of this open and randomized phase 2
clinical trial will be 6 days. The estimated number of persons with acute fever of viral
etiology to be recruited and randomized for the study is 200. The primary outcome measure:
platelet, leukocyte and granulocyte count will be assessed at the beginning and the end of
the study.